Albert de Graaf (Scientific Coordinator of POWER2DM ) joined TNO in 2006 and works as a Senior Scientist coordinating activities on computational modelling for Predictive Health Technolgies. He participated in several recent FP7 projects including MISSION-T2D and NuAge. The main modelling application areas are lipoprotein metabolism, cholesterol metabolism, gut microbial metabolism, metabolic disease and diagnostics, and systems medicine. Prior to TNO, he worked at Delft University of Technology (biological applications of Nuclear Magnetic Resonance), Philips Medical Systems BV (MRI/MRS techniques), Forschungszentrum Jülich, Germany (modelling and flux analysis of microbial metabolism for Metabolic Engineering purposes), and University of Maastricht (Metabolic pathway modeling and analysis). He was also co-founder and CSO of the French biotech company Metabolic Explorer SA Albert de Graaf (Scientific Coordinator of POWER2DM ) joined TNO in 2006 and works as a Senior Scientist coordinating activities on computational modelling for Predictive Health Technolgies. He participated in several recent FP7 projects including MISSION-T2D and NuAge. The main modelling application areas are lipoprotein metabolism, cholesterol metabolism, gut microbial metabolism, metabolic disease and diagnostics, and systems medicine. Prior to TNO, he worked at Delft University of Technology (biological applications of Nuclear Magnetic Resonance), Philips Medical Systems BV (MRI/MRS techniques), Forschungszentrum Jülich, Germany (modelling and flux analysis of microbial metabolism for Metabolic Engineering purposes), and University of Maastricht (Metabolic pathway modeling and analysis). He was also co-founder and CSO of the French biotech company Metabolic Explorer SA

Medicine, Healthcare, Hospitals,Hospital Management,etc